Evaluation of UHRF1 and P16INK4A expression levels in newly diagnosed AML patients. Biomed. Res. Ther. [Internet]. 2018 Sep. 27 [cited 2024 Nov. 15];5(9):2658-63. Available from: https://preservation.bmrat.org/index.php/BMRAT/article/view/475